[The antiviral effect of tilorone HCl derivatives against TBE in mice (author's transl)].
D000284:Administration, Oral; D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use*; D055598:Chemical Phenomena; D002621:Chemistry; D004359:Drug Therapy, Combination; D004675:Encephalitis, Tick-Borne / Q000517:prevention & control*; D005021:Ethylamines / Q000627:therapeutic use; D005449:Fluorenes / Q000627:therapeutic use*; D007274:Injections, Intraperitoneal; D007279:Injections, Subcutaneous; D007369:Interferon Inducers; D007372:Interferons / Q000097:blood; D007659:Ketones / Q000627:therapeutic use; D051379:Mice; D011070:Poly I-C / Q000627:therapeutic use; D013223:Statistics as Topic
D000998:Antiviral Agents; D005021:Ethylamines; D005449:Fluorenes; D007369:Interferon Inducers; D007659:Ketones; D007372:Interferons; D011070:Poly I-C
Die antivirale Wirkung von einigen Derivaten des Tilorone HCl gegen die Frühsommer-Meningoenzephalitis (FSME) der weissen Maus.